Emerging concepts in heart failure management and treatment: circulatory support with extracorporeal membrane oxygenation (ECMO).

40 Another single-centre randomized trial of 256 OHCA patients showed a trend toward improved survival with minimal or no neurological impairment at 180 days (31.5% and 22.0% for ECPR and CPR, respectively, absolute difference of +9.5%, 95% CI –1.3 to 20.1; p =0.09) and similar trend in the rate of cardiac recovery at 30 days (43.5% and 34.1% for ECPR and CPR, respectively;

also in 53,322 other papers